At the time of writing, West Pharmaceutical Services, Inc [WST] stock is trading at $280.84, up 2.50%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The WST shares have gain 7.96% over the last week, with a monthly amount drifted -2.22%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
West Pharmaceutical Services, Inc [NYSE: WST] stock has seen the most recent analyst activity on September 15, 2025, when Rothschild & Co Redburn initiated its Buy rating and assigned the stock a price target of $311. Previously, Barclays started tracking the stock with Equal Weight rating on June 24, 2025, and set its price target to $245. On March 18, 2025, Evercore ISI initiated with an Outperform rating and assigned a price target of $275 on the stock. Deutsche Bank upgraded its rating to a Buy but stick to its price target of $250 on February 14, 2025. Citigroup initiated its recommendation with a Buy and recommended $400 as its price target on January 08, 2025. In a note dated December 12, 2024, UBS upgraded a Buy rating on this stock and boosted its target price from $350 to $390.
For the past year, the stock price of West Pharmaceutical Services, Inc fluctuated between $187.43 and $348.90. Currently, Wall Street analysts expect the stock to reach $345.2 within the next 12 months. West Pharmaceutical Services, Inc [NYSE: WST] shares were valued at $280.84 at the most recent close of the market. An investor can expect a potential return of 22.92% based on the average WST price forecast.
Analyzing the WST fundamentals
According to West Pharmaceutical Services, Inc [NYSE:WST], the company’s sales were 3.02B for trailing twelve months, which represents an 7.69% jump. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.2%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.17 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 277.24 points at the first support level, and at 273.63 for the second support level. However, for the 1st resistance point, the stock is sitting at 282.89, and for the 2nd resistance point, it is at 284.93.
Ratios To Look Out For
It is important to note that West Pharmaceutical Services, Inc [NYSE:WST] has a current ratio of 2.87. Further, the Quick Ratio stands at 2.18, while the Cash Ratio is 0.99. Considering the valuation of this stock, the price to sales ratio is 6.70, the price to book ratio is 6.62 and price to earnings (TTM) ratio is 41.60.
